UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy
Clinical trial NCT00083551 · COMPLETED
Trial details
- NCT number
- NCT00083551
- Sponsor
- University of Arkansas
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1998-08-01
- Primary completion
- 2014-08-01
- Enrollment
- 668
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.